Similar Articles |
|
American Family Physician November 15, 2000 John R. Brill & Dennis J. Baumgardner |
Normocytic Anemia ...Normocytic anemia is the most frequently encountered type of anemia. Anemia of chronic disease, the most common normocytic anemia, is found in 6 percent of adult patients hospitalized by family physicians.... |
American Family Physician August 2001 Alexander K.C. Leung |
Evaluating the Child with Purpura Purpura is the result of hemorrhage into the skin or mucosal membrane. It may represent a relatively benign condition or herald the presence of a serious underlying disorder... |
American Family Physician October 1, 2000 Douglas L. Smith |
Anemia in the Elderly Anemia should not be accepted as an inevitable consequence of aging. A cause is found in approximately 80 percent of elderly patients. The most common causes of anemia in the elderly are chronic disease and iron deficiency... |
American Family Physician July 1, 2006 Junnila & Cartwright |
Chronic Musculoskeletal Pain in Children: Part I. Initial Evaluation Musculoskeletal pain can be difficult for children to characterize. A logical and consistent approach to diagnosis is recommended, with judicious use of laboratory and radiologic testing. |
American Family Physician September 15, 2000 Doris L. Wethers, M.D. |
Sickle Cell Disease in Childhood Part II. Diagnosis and Treatment of Major Complications and Recent Advances in Treatment |
American Family Physician November 15, 2003 Cooper et al. |
Primary Immunodeficiencies Primary immunodeficiencies include a variety of disorders that render patients more susceptible to infections. If left untreated, these infections may be fatal. The disorders constitute a spectrum of more than 80 innate defects in the body's immune system. |
American Family Physician June 1, 2004 Dhaliwal, Cornett & Tierney |
Hemolytic Anemia While hemolysis can be a lifelong asymptomatic condition, it most often presents as anemia when erythrocytosis cannot match the pace of red cell destruction. Hemolysis also can manifest as jaundice, cholelithiasis, or isolated reticulocytosis. |
Managed Care January 2006 Thomas Morrow |
Four-Color Flow Cytometry Detects Minimal Residual Disease in Leukemia Should a new - and cheap - test for chronic lymphocytic leukemia be a component of prior-authorization protocols? |
American Family Physician July 15, 2006 Mehta et al. |
Opportunities to Improve Outcomes in Sickle Cell Disease Family physicians play a crucial role in instituting evidence-based preventive sickle cell care strategies, initiating timely treatment of acute illness, recognizing life-threatening episodes, and providing a medical home for multidisciplinary management. |
American Family Physician May 1, 2004 Stuart & Viera |
Polycythemia Vera Polycythemia vera is a chronic myeloproliferative disorder characterized by increased red blood cell mass. The resultant hyperviscosity of the blood predisposes such patients to thrombosis. Untreated patients may survive for six to 18 months, whereas adequate treatment may extend life expectancy to more than 10 years. |
Nursing November 2011 Jeanne Held-Warmkessel |
Taming Three High-Risk Chemotherapy Complications A review of three common chemotherapy-associated complications that can be serious enough to require hospitalization: febrile neutropenia, chemotherapy-related nephrotoxicity, and chemotherapy-related enterotoxicity. |
American Journal of Nursing May 2012 Wright et al. |
Posterior Reversible Encephalopathy Syndrome: A Case Study Posterior reversible encephalopathy syndrome is a rare neurologic disorder characterized by an acute increase in blood pressure, and by headaches, altered mental status, seizures, and visual loss. |
Nursing June 2010 Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
American Family Physician November 1, 2005 Eddie Needham |
Management of Acute Renal Failure Acute renal failure is an acute loss of kidney function that occurs over days to weeks and results in an inability to appropriately excrete nitrogenous wastes and creatinine. In spite of this rapid decline in kidney function, patients with acute renal failure often have few symptoms. |
Nursing February 2010 Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
Chemistry World August 28, 2012 Andrew Turley |
Myelofibrosis drug approved in EU Jakavi (ruxolitinib) tablets have been approved in the EU for the treatment of myelofibrosis, a rare disease affecting the bone marrow. |
American Family Physician November 1, 2006 Lyon & Clark |
Diagnosis of Acute Abdominal Pain in Older Patients Acute abdominal pain is a common presenting complaint in older patients, but may be difficult to diagnose. Here are some common causes of abdominal pain in old patients and recommendations for treatment. |
Nursing March 2010 Peg Gray-Vickrey |
Gathering pearls of knowledge for assessing older adults If you attended nursing school more than 10 years ago, you may have received limited education about gerontological nursing. But as baby boomers age, this is becoming an increasingly important area of nursing practice. |
Chemistry World March 28, 2014 Michael Parkin |
Rare-cell analysis platform pursues neurodegeneration answers A technique for spotting the small numbers of immune cells that cross the blood -- brain barrier into the cerebral spinal fluid may offer early clues on neurodegenerative disease progression. |
Pharmaceutical Executive July 1, 2011 Dickmeyer & Rosenbeck |
From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition? |
Pharmaceutical Executive April 10, 2014 Ben Comer |
Sickle Cell Disease In Three Acts Is there a happy ending in store for sickle cell patients? |
American Family Physician July 1, 2003 Siva et al. |
Diagnosing Acute Monoarthritis in Adults: A Practical Approach Acute monoarthritis can be the initial manifestation of many joint disorders. Because patients with acute monoarthritis often present to their family physician, a proper diagnostic approach is important. |
BusinessWeek December 6, 2004 Catherine Arnst |
Cord Blood To The Rescue A study in the Nov. 25 issue of The New England Journal of Medicine confirms that stem cells in blood extracted from the umbilical cords of newborns can help leukemia patients |
Pharmaceutical Executive October 1, 2012 Ben Comer |
Stem Cells: A Promise Deferred? Ideology, politics, and a stilted political debate may be causing pharma to overlook the potential of emerging stem cell therapies in fostering a new generation of cures. |
American Family Physician May 1, 2004 |
Polycythemia Vera A general overview on Polycythemia Vera, a disease in which the body makes too many red blood cells. |
HHMI Bulletin May 2011 Jim Schnabel |
Oxygen on the Brain An ancient cellular program to protect cells when oxygen is low seems crucial for the production of new brain cells. |
IEEE Spectrum February 2005 Carol Ezzell Webb |
The Body Shops Part human, part machine, replacement organs may one day extend your life |
HHMI Bulletin May 2011 Dan Ferber |
Revealing the Biological Complexity of Bones Bones are the body's framework and support, our strongest tissues. Unlike the scaffold of a building, however, bones are anything but inert. They pulse with life and their maintenance requires a surprisingly delicate balancing act. |
Scientific American January 2009 Charles Q. Choi |
Do White Blood Cells Make Cancer Deadly? The ability to spread underlies the killing power of cancer. The process occurs, John Pawelek thinks, when tumor cells fuse with white blood cells -- an idea that, if right, could yield new therapies |
HHMI Bulletin Nov 2010 Mitch Leslie |
Immune System Defects Can Cause Obsessive Behavior A shortage of certain immune cells might prompt obsessive-compulsive disorder. |
IEEE Spectrum August 2006 Schoenbach et al. |
Zap Extreme voltage could be a surprisingly delicate tool in the fight against cancer. The list of effects that scientists have achieved using nanoseconds-long pulses is growing rapidly, though their actual use as a medical treatment is still years away. |
HHMI Bulletin May 2010 Sarah C.P. Williams |
Young Again Niche cells can reverse the aging of stem cells. |
BusinessWeek September 5, 2005 Kerry Capell |
Meeting Leukemia's Diagnostic Challenge Tests that distinguish among the disease's many forms either cost too much or don't exist. Dr. Torsten Haferlach And Switzerland's Roche Diagnostics may have a solution. |
HHMI Bulletin Aug 2011 Richard Saltus |
T-Cell Booster Kits A bioengineer remodels cell surfaces to prod the immune system. |
The Motley Fool December 11, 2008 Brian Orelli |
ASH Wrap-Up: Alphabet Soup and Drugs Let's take a look at the data that came out of the American Society of Hematology meeting regarding pharmaceutical companies' medications for blood diseases. |
Scientific American March 2009 Elaine Schattner |
A Chip against Cancer: Microfluidics Scrutinizes T Cells With just a blood sample, a device could determine whether cancer is about to spread or monitor the progress of treatment |
Chemistry World June 11, 2015 Sarah Houlton |
Companies clamour for CAR-T The biopharmaceutical industry is getting excited about chimeric antigen receptor T-cells, or CAR-T cells, designed to harness the cell-killing power of the immune system. |
Chemistry World February 9, 2012 Harriet Brewerton |
Pressurizing red blood cells for information Scientists in Canada have developed a method to study the changes in red blood cells caused by the most common malaria parasite Plasmodium falciparum. |
Popular Mechanics January 28, 2010 Cassie Rodenberg |
Next-Gen Transplant Techniques Can Stop Organ Rejection About 77 organ transplants are performed each day in the U.S., and more than 101,000 people are on a wait list for body parts such as hearts, skin and veins, according to the Mayo Clinic. |
BusinessWeek June 27, 2005 Arlene Weintraub |
Stem Cells To Go ViaCell's goal is to mass-produce stem cells from umbilical cord blood. |
American Family Physician October 1, 2000 Gary A. Ratkin, M.D. |
Book Review Current Therapy in Cancer By John F. Foley, Julie M. Vose and James O. Armitage contains useful sections and chapters, but other texts provide this information in a more consistent style... |
The Motley Fool December 22, 2009 Brian Orelli |
Pfizer Swings for the Fences A long shot, but at least it's cheap. Pfizer seems to have taken a particular liking to stem cells, having established a unit to study them last year |
The Motley Fool January 31, 2011 Brian Orelli |
Time to Buy Into Stem Cells? New developments bring this analyst a step closer to opening his wallet. |
Popular Mechanics December 16, 2008 Michael Milstein |
Bringing Stem Cells to War: Meet the Blood Pharmers Fresher blood is better than stale: It carries more oxygen and, when transfused into patients, speeds recovery. |
The Motley Fool November 9, 2004 Charly Travers |
Are Stem Cells a Rule Breaker? Does the science offer real hope or just hype? Biotech investors take on enough risk in the normal course of drug development that they do not need to worry about whether or not the underlying technology even works. |
Chemistry World April 10, 2008 Sarah Houlton |
Radiotherapy Side-Effects Suppressed A new drug being developed by scientists at Cleveland BioLabs (CBLI) in the US may hold the key to protecting healthy cells from the effects of radiotherapy during cancer treatment. |
The Motley Fool June 10, 2011 Brian Orelli |
Great Data! Now Lets See More Than 12 Patients Micromet's blinatumomab looks good in a phase 2 trial. |
Chemistry World October 2010 |
Artificial blood Synthetic alternatives to donor blood have been stuck in development for decades. Nina Notman reports on recent promising progress |
Reactive Reports Issue 64 David Bradley |
Stem to Sperm New research shows that stem cells from human bone marrow can be converted into early-stage sperm. The discovery could lead to novel fertility treatments in the long-term. |
HHMI Bulletin Aug 2010 Richard Saltus |
Three-Dimensional Cell Cultures Thinking big but starting small, Sangeeta Bhatia is closing in on her ambitious goal: growing human livers in the lab from scratch. |